Glaucoma is an eye disorder that causes damage to the optic nerve if left untreated, leading to the permanent loss of vision. As per the report that has been published by Market research Future (MRFR), the global glaucoma surgery market is registered to expand at a noteworthy CAGR of 7.9% during the forecast period of 2017-2023.
Market Drivers and Restraints:
Glaucoma is considered to be one of the leading causes of preventable blindness. With the rise in geriatric population, the incidences of glaucoma are increasing resulting in the high demand for surgical treatments, which in turn is fueling the growth of the global glaucoma surgery market.
Increasing inclination towards permanent and faster cure through surgery over long-term use of medication is one of the major drivers of the global glaucoma surgery market. In addition, rise in prevalence of causative disorders such as diabetes and ocular hypertension are inducing need for surgical treatments, leading to the expansion of the global glaucoma surgery market.
However, lack of awareness, preference of non-invasive treatments and high cost associated with the treatment are likely to create hindrance in the growth of the global glaucoma surgery market during the forecast period.
Fill Out Details To Receive FREE Sample Here: https://www.marketresearchfuture.com/sample_request/1342
The leading players profiled by MRFR in the report on the global glaucoma surgery market are Novartis AG (Switzerland), Allergan (the U.S.), Merck & Co., Inc. (the U.S.), Abbott (the U.S.), Akorn, Inc. (the U.S.), Teva Pharmaceuticals (the U.S.), Bausch & Lomb (the U.S.), Pfizer, Santen (Japan), Carl Zeiss Meditec (Germany), Alcon (the U.S.), Ellex Medical Lasers (Australia), Lumenis (the U.S.), Topcon Medical Systems (the U.S.), Nidek (the U.S.), OPHTEC (the U.S.), Optos (the U.S.), Accutome (the U.S.), AqueSys (Taiwan), Canon (Japan), Essilor (France) and Iridex Corporation (the U.S.)
In August 2018, Alcon, a Novartis subsidiary, has announced a voluntary global recall of CyPass Micro-Stent which is a micro-invasive glaucoma surgical device due to safety issues.
In August 2018, the U.S. Food and Drug Administration (FDA) has approved Hydrus Microstent, a device used for micro-invasive glaucoma surgery (MIGS) in patients with moderate to mild primary open-angle glaucoma.
The global glaucoma surgery market has been segmented on the basis of target, surgery and end-user. Based on target, the glaucoma surgery market is segmented into trabecular meshwork, suprachoroidal space and others. Based on surgery, the glaucoma surgery market is segmented into angle closure glaucoma surgery, aqueous shunt surgery, laser surgery and others. Based on end users, the glaucoma surgery market is segmented into hospital, ambulatory surgery centers and others.
The global glaucoma surgery market is geographically segmented into four major regions such as North America, Asia Pacific, Europe and the Middle East and Africa. The North America region is leading the global glaucoma surgery market with respect to market size. The high number of population suffering from diabetes and other eye disorder and increasing healthcare expenditure are some of the major factors that are fueling the growth of the glaucoma surgery market in this region.
The Europe region is registered to be the second largest market for glaucoma surgery owing to the increased research and development for introduction of advanced surgical devices in this region. The Asia Pacific region is projecting significant growth in the global glaucoma surgery market owing to the large population base and increasing prevalence of glaucoma in this region.
Browse Complete Report : https://www.marketresearchfuture.com/reports/glaucoma-surgery-market-1342
Table Of Content : Glaucoma Surgery Market
1.2 SCOPE OF STUDY
1.2.1 RESEARCH OBJECTIVE
1.2.2 ASSUMPTIONS & LIMITATIONS
1.3 MARKET STRUCTURE:
2.1 RESEARCH PROCESS
2.2 PRIMARY RESEARCH
2.3 SECONDARY RESEARCH
3.4 MACROECONOMIC INDICATORS
4.MARKET FACTOR ANALYSIS
4.1 PORTERS FIVE FORCES MODEL
4.2 BARGAINING POWER OF SUPPLIERS
4.3 BARGAINING POWER OF BUYERS
4.4 THREAT OF NEW ENTRANTS
4.5 THREAT OF SUBSTITUTES
4.6 INTENSITY OF RIVALRY
5.GLOBAL GLAUCOMA SURGERY MARKET, BY TARGET
5.1 TRABECULAR MESHWORK
5.2 SUPRACHOROIDAL SPACE
6.GLOBAL GLAUCOMA SURGERY MARKET, BY TYPE OF SURGERY
6.1 ANGLE CLOSURE GLAUCOMA SURGERY
6.2 AQUEOUS SHUNT SURGERY
6.3 LASER SURGERY
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Company Name: Market Research Future
Contact Person: Abhishek Sawant
Email: Send Email
Phone: +1 646 845 9312
Address:Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar